26Jan/14

BioLineRx's BL-8040 receives US orphan drug status for stem cell mobilization … – pharmabiz.com

BioLineRx’s BL-8040 receives US orphan drug status for stem cell mobilization
pharmabiz.com
Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow metastasis of lymphoma cells and stimulating lymphoma cell death. BL-8040 also mobilizes stem cells from the 

26Jan/14

Patient groups protest Wash. state insurance rules requiring waiting period … – Washington Post

Patient groups protest Wash. state insurance rules requiring waiting period
Washington Post
Susanna Nazarian, assistant professor of transplant surgery at the University of Washington, put it more bluntly: “Putting this additional barrier in front of them will lead to some patients passing away.” Insurance company representatives said they

and more »